Aescuvest
VC Fund
Frankfurt, Germany
Aescuvest is a VC fund in Frankfurt focused on Health Care and Medical. Aescuvest’s mission is to facilitate and enable impactful investments into medical breakthrough innovation to disrupt and improve healthcare delivery models, products, and services. Aescuvest enables its investors to build their very individual portfolio of healthcare start-ups - according to their personal investment focus. A cooperation with EITHealth, and a growing network of partnerships across Europe, allow Aescuvest to source and evaluate the most promising healthcare investment opportunities, structure their financing rounds, and enable healthcare technology-driven investors, such as Business Angels, HNWIs, Family Offices, and Corporate Investors, to participate in healthcare investment opportunities by direct investments via SPV structures. The Investment Committee, composed of Aescuvest’s very own investment team and members of tthe Advisory Board of Aescuvest, both deeply rooted in the healthcare industry and with proven track records, have developed a strong and over the last years well tested, pre-screening and due diligence process, to identify and select healthcare start-ups. Aescuvest’’s Management (circle of General Partners) put their ‘skin’ into each investment by committing capital to each company prior introduction to the wider Aescuvest investor base. The combination of innovative ways for equity capital provision, with healthcare industry and investment expertise, provides the Aescuvest portfolio companies a unique platform to develop their business solution, accelerate their path towards commercialization, and lower market access barriers.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Aescuvest invests in
Stages Aescuvest invests in
Countries Aescuvest invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.1M–$2.3M
- Equity Crowdfunding
- $116k–$666k
Investment Focus
Industry
- Health Care 16 (62%)
- Medical 7 (27%)
- Medical Device 5 (19%)
- Biotechnology 3 (12%)
- Pharmaceutical 3 (12%)
Stage
- Equity Crowdfunding 15 (58%)
- Seed 3 (12%)
- Pre-Seed 1 (4%)
- Series A 1 (4%)
- Series B 1 (4%)
Country
- Germany 18 (69%)
- Israel 1 (4%)
- Austria 1 (4%)
- United States 1 (4%)
- The Netherlands 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sebastian Gührs
Head of Investment
|
Head of Investment | Total investments: 4 | Find email | |
Alexander Vogt
Relationship Manager
|
Relationship Manager | Total investments: 0 | Find email | |
Ayla Haddenhorst
Relationship Manager
|
Relationship Manager | Total investments: 0 | Find email | |
Christine Schmieder
Investor Relations Manager
|
Investor Relations Manager | Total investments: 0 | Find email | |
Christoph Bartoschek
Startup Relations Manager
|
Startup Relations Manager | Total investments: 1 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
XO Life
|
XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications. | $7.8M / Venture - Series Unknown / Aug 22, 2024 | |
Caresyntax
|
Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around theOR.Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients. | $80M / Series C / Aug 15, 2024 | |
Neteera
|
Neteera is bridging the gap between the human or analog world and the digital world by enabling seamless, continuous and contact-free monitoring of human vital signs.Neteera's micro-radar on chip and proprietary algorithms sense microscopic skin motions, even through furniture and clothing. This takes place at a very high frequency, allowingfor non-invasive, seamless and continuous monitoring of human vital signs such as heart and respiration rates, heart rate variability, inhale-exhale ratio, tidal volume and more. | $6.7M / Series B / Oct 31, 2023 | |
Lillian Care
|
Lillian is building a nationwide network of health facilities in Germany. | $2.6M / Pre-Seed / Aug 01, 2023 | |
|
Neteera
|
Neteera is bridging the gap between the human or analog world and the digital world by enabling seamless, continuous and contact-free monitoring of human vital signs.Neteera's micro-radar on chip and proprietary algorithms sense microscopic skin motions, even through furniture and clothing. This takes place at a very high frequency, allowingfor non-invasive, seamless and continuous monitoring of human vital signs such as heart and respiration rates, heart rate variability, inhale-exhale ratio, tidal volume and more. | $13M / Series B / Apr 12, 2023 | |
piur imaging
|
PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules. | $5.3M / Series A / Apr 05, 2023 | |
|
XO Life
|
XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications. | $2.3M / Seed / Feb 16, 2022 | |
Medikura
|
Medikura provides communication infrastructure enabling multidirectional drug-related information exchange between patients, medical experts, and pharma to improve drug effectiveness and safety setting. | $1.2M / Seed / Jan 01, 2022 | |
Munevo
|
Munevo empowers people with disabilities by using smart and innovative technology. | $1.1M / Seed / Nov 01, 2020 | |
Emperra
|
Emperra E-Health Technologies develops GSM and web based Tele-medical products for tracking, monitoring, and transmission of diagnostic and therapeutic data of diabetic patients such as insulin doses, blood sugar levels and carbohydrates. The company was founded in 2008 and is based in Potsdam, Germany. | $810.7K / Equity Crowdfunding / May 11, 2020 | |
| See all 26 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Aescuvest invest in?
Aescuvest invests primarily in Health Care, Medical and Medical Device startups, most often at Equity Crowdfunding and Seed stage. Most of the 26 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Aescuvest's check size?
Aescuvest typically joins rounds of $1.1M–$2.3M at Seed and $116k–$666k at Equity Crowdfunding. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Aescuvest participates in.
How do I contact Aescuvest?
Public channels for Aescuvest include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Aescuvest?
The team at Aescuvest includes Sebastian Gührs (Head of Investment), Alexander Vogt (Relationship Manager) and Ayla Haddenhorst (Relationship Manager), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
